Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,051,504
+$3,597,062 QoQ
Shares Held
43,515
+42.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.82%
of 13F equity value
Holder Rank
#1,052
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Family Manage LLC holds $23,478,755 across 9 Drug Manufacturers - General names. JNJ ranks #1 (47.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
43,515 | $11,051,504 | |
| 2 | MRK |
Merck & Co., Inc.
|
34,626 | $4,449,441 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
29,547 | $3,732,967 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
20,516 | $1,182,131 | |
| 5 | LLY |
ELI LILLY & Co
|
890 | $1,067,492 | |
| 6 | ABBV |
AbbVie Inc.
|
4,143 | $1,042,544 | |
| 7 | AMGN |
Amgen Inc
|
1,027 | $371,897 | |
| 8 | PFE |
Pfizer Inc
|
15,274 | $367,797 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,051,504 | 43,515 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,454,442 | 30,496 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,917,907 | 38,260 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,848,116 | 36,933 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,554,601 | 36,364 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,841,879 | 35,226 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,143,941 | 28,654 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,650,311 | 28,695 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,079,033 | 27,908 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,278,723 | 27,048 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $6,149,693 | 39,235 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,077,053 | 39,018 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,756,360 | 40,819 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,398,555 | 41,281 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,353,586 | 41,628 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $6,772,415 | 41,457 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,418,406 | 36,158 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,816,974 | 38,464 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $6,437,706 | 37,632 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,991,327 | 37,098 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $6,327,828 | 38,411 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $5,601,541 | 34,083 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $5,323,221 | 33,824 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $4,494,836 | 30,191 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $4,552,614 | 32,373 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $4,094,009 | 31,221 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||